EcoDrugPlus

Integrin Subunit Beta 8

Ensembl ID : ENSBGRG00000001411
Gene Symbol: ITGB8
1 Cross references
207 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSBGRG00000019405
Gene Symbol: IRAK4
1 Cross references
202 Possible Orthologues:

Interleukin 5

Ensembl ID : ENSBGRG00000003095
Gene Symbol: IL5
1 Cross references
91 Possible Orthologues:

Interleukin 6

Ensembl ID : ENSBGRG00000000868
Gene Symbol: IL6
1 Cross references
162 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSBGRG00000006637
Gene Symbol: IDH1
1 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSBGRG00000006356
Gene Symbol: IDH2
1 Cross references
261 Possible Orthologues:

Kallikrein B1

Ensembl ID : ENSBGRG00000016181
Gene Symbol: KLKB1
1 Cross references
209 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSBGRG00000023842
Gene Symbol: KDR
1 Cross references
199 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSBGRG00000020999
Gene Symbol: KIF11
1 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSBGRG00000023175
Gene Symbol: KIF5B
1 Cross references
288 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSBGRG00000006246
Gene Symbol: LTA4H
1 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSBGRG00000019850
Gene Symbol: LTB4R
1 Cross references
141 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).